FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Leadiant Biosciences Cystaran Recall

Cystaran (cysteamine ophthalmic solution) 0

LEADIANT BIOSCIENCES, INC · Gaithersburg, MD

Risk level
Class III
Reported by FDA
Apr 25, 2018
Recall ID
D-0683-2018
Check your lot numberHow we source this data

Summary

Leadiant Biosciences recalled Cystaran starting Apr 9, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0683-2018 on Apr 25, 2018. Reason: Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride. Status: Terminated.

Why it was recalled

Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.

Product description

Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc. Amityville, NY 11701 for Leadiant Biosciences, Inc. Gaithersburg, MD 20878, NDC 54482-020-01

Lot numbers, UPCs & expiration codes

lot numbers: 35866, Exp 6/18; 358663, Exp 7/18

Where it was sold

Walgreens Specialty Pharmacy Pittsburg, PA Italy and Germany

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0683-2018
Classification
Class III
Status
Terminated
Recall initiated
Apr 9, 2018
FDA report date
Apr 25, 2018
Quantity
3,398 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
LEADIANT BIOSCIENCES, INC

Original FDA data

Every field from FDA enforcement report D-0683-2018, exactly as published.

Show all FDA fields
City
Gaithersburg
State
MD
Status
Terminated
Country
United States
Event ID
79849
Address
9841 Washingtonian Blvd Ste 500
Code information
lot numbers: 35866, Exp 6/18; 358663, Exp 7/18
Postal code
20878-7352
Report date
Apr 25, 2018
Product type
Drugs
Recall number
D-0683-2018
Classification
Class III
Recalling firm
LEADIANT BIOSCIENCES, INC
Product quantity
3,398 bottles
Termination date
Nov 29, 2018
Reason for recall
Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc. Amityville, NY 11701 for Leadiant Biosciences, Inc. Gaithersburg, MD 20878, NDC 54482-020-01
Distribution pattern
Walgreens Specialty Pharmacy Pittsburg, PA Italy and Germany
Recall initiation date
Apr 9, 2018
Initial firm notification
Letter
Center classification date
Apr 17, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0683-2018, published Apr 25, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls